SCHEMBL10185551

SCHEMBL10185551

O=C1C(N(C(=O)COc2ccccn2)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.37
▸ HTT P42858 1/20 0.35
▸ OPRM1 P35372 2/20 0.35
▸ OPRK1 P41145 2/20 0.35
▸ OPRL1 P41146 2/20 0.35
▸ LMNA P02545 3/20 0.35
▸ TRPM8 Q7Z2W7 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ IDH1 O75874 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HCRTR1 O43613 1/20 0.33
▸ HCRTR2 O43614 1/20 0.33
▸ AGTR2 P50052 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183311 0.91 IDH1 (0.34) NPC1HTTKMT2AALDH1A1IDH1
SCHEMBL10183676 0.89 HCRTR1 (0.35) NPC1OPRM1OPRK1OPRL1TRPM8
SCHEMBL10183761 0.88 TRPM8 (0.42) OPRM1OPRK1OPRL1LMNATRPM8
SCHEMBL10185558 0.88 NPC1 (0.36) NPC1HTTOPRM1OPRK1OPRL1
SCHEMBL10185587 0.87 TRPM8 (0.41) OPRM1OPRK1OPRL1LMNATRPM8
SCHEMBL10184008 0.86 PTGIR (0.38) NPC1OPRM1OPRK1OPRL1TRPM8
SCHEMBL10184119 0.85 OPRM1 (0.37) OPRM1OPRK1OPRL1LMNATRPM8
SCHEMBL10183299 0.84 OPRM1 (0.40) HTTOPRM1OPRK1OPRL1LMNA
SCHEMBL10185933 0.84 GRM5 (0.40) OPRM1OPRK1OPRL1MEN1KMT2A
SCHEMBL10183337 0.83 OPRM1 (0.39) NPC1HTTOPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback